latest news releases from the newsroom
Levi & Korsinsky, LLP
Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of Central Jersey Bancorp
NEW YORK, May 28, 2009 (GLOBE NEWSWIRE) -- Levi & Korsinsky ("L&K") is investigating breaches of fiduciary duty and other violations of state law by the Board of Directors of Central Jersey Bancorp ("Central Jersey" or the "Company") (Nasdaq:CJBK) arising out of their attempt to sell the Company to OceanFirst Financial Corp ("OceanFirst") (Nasdaq:OCFC). Under the terms of the agreement, Central Jersey shareholders will receive 0.5 shares of OceanFirst stock for each share of OceanFirst they own. Based on the May 26, 2009 closing price of OceanFirst stock at $14.23 per share, the transaction values Central Jersey shares at $7.12 for a total deal value of approximately $68.4 million. The price is unfair given that Central Jersey shares traded at $7.50 per share as recently as February 10, 2009 and the 60-day average of OceanFirst shares is only $11.91 per share.
Generex Biotechnology Corp.
Generex Scientist to Participate in Panel Discussion At Swine Influenza Symposium
WORCESTER, Mass., May 28, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. (www.antigenexpress.com), Generex's wholly-owned immunotherapeutics subsidiary, will participate in a panel discussion this afternoon at the Human Swine Flu (H1N1) and Novel Influenza Pandemics symposium being hosted by The New York Academy of Sciences (NYAS) to be held at the NYAS conference center in New York City. The symposium will feature presentations by leaders in the field and will explore the latest swine influenza (H1N1 flu) outbreak with talks on the new reassortant virus, epidemiology, vaccines, treatment, and public health aspects.